GETI.B

193.45

+0.86%↑

VITR

159.8

+1.98%↑

AMBEA

108.7

+1.4%↑

ARJOB

30.6

-0.65%↓

MSON.B

8.6

-1.38%↓

GETI.B

193.45

+0.86%↑

VITR

159.8

+1.98%↑

AMBEA

108.7

+1.4%↑

ARJOB

30.6

-0.65%↓

MSON.B

8.6

-1.38%↓

GETI.B

193.45

+0.86%↑

VITR

159.8

+1.98%↑

AMBEA

108.7

+1.4%↑

ARJOB

30.6

-0.65%↓

MSON.B

8.6

-1.38%↓

GETI.B

193.45

+0.86%↑

VITR

159.8

+1.98%↑

AMBEA

108.7

+1.4%↑

ARJOB

30.6

-0.65%↓

MSON.B

8.6

-1.38%↓

GETI.B

193.45

+0.86%↑

VITR

159.8

+1.98%↑

AMBEA

108.7

+1.4%↑

ARJOB

30.6

-0.65%↓

MSON.B

8.6

-1.38%↓

Search

Vivesto AB

Atvērts

0.22

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.22

Max

0.22

Galvenie mērījumi

By Trading Economics

Ienākumi

-451K

-11M

EPS

-0.02

Darbinieki

4

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 12. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-5.9M

124M

Iepriekšējā atvēršanas cena

0.22

Iepriekšējā slēgšanas cena

0.22

Vivesto AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 19. maijs 20:40 UTC

Iegādes, apvienošanās, pārņemšana

FedEx Names CEO, Chairman for Planned Freight Spinoff

2025. g. 20. maijs 00:00 UTC

Top Ziņas

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

2025. g. 19. maijs 23:48 UTC

Tirgus saruna

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

2025. g. 19. maijs 23:43 UTC

Tirgus saruna

Gold Edges Lower on Possible Technical Correction -- Market Talk

2025. g. 19. maijs 23:22 UTC

Top Ziņas

Crypto Billionaire Accused of Defrauding Creditors, Propelling Industry's 2022 Collapse -- WSJ

2025. g. 19. maijs 22:33 UTC

Tirgus saruna

Uranium Buyers Could Accelerate Restocking -- Market Talk

2025. g. 19. maijs 22:16 UTC

Iegādes, apvienošanās, pārņemšana

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

2025. g. 19. maijs 22:16 UTC

Iegādes, apvienošanās, pārņemšana

Yuexiu Property to Sell Stake for CNY4.15B

2025. g. 19. maijs 22:15 UTC

Iegādes, apvienošanās, pārņemšana

Yuexiu Property to Sell Stake to China Resources Land

2025. g. 19. maijs 22:15 UTC

Iegādes, apvienošanās, pārņemšana

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

2025. g. 19. maijs 22:02 UTC

Peļņas

Trip.com Group 1Q Rev $1.9B >TCOM

2025. g. 19. maijs 22:02 UTC

Peļņas

Trip.com Group 1Q Adj EPS 82c >TCOM

2025. g. 19. maijs 22:02 UTC

Peļņas

Trip.com Group 1Q EPS 84c >TCOM

2025. g. 19. maijs 21:58 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 19. maijs 21:58 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 19. maijs 21:58 UTC

Tirgus saruna

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

2025. g. 19. maijs 21:50 UTC

Top Ziņas
Peļņas

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

2025. g. 19. maijs 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 19. maijs 20:48 UTC

Top Ziņas

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

2025. g. 19. maijs 20:21 UTC

Iegādes, apvienošanās, pārņemšana

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

2025. g. 19. maijs 20:21 UTC

Iegādes, apvienošanās, pārņemšana

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

2025. g. 19. maijs 20:21 UTC

Iegādes, apvienošanās, pārņemšana

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

2025. g. 19. maijs 20:21 UTC

Iegādes, apvienošanās, pārņemšana

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

2025. g. 19. maijs 20:21 UTC

Iegādes, apvienošanās, pārņemšana

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

2025. g. 19. maijs 20:20 UTC

Top Ziņas

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

2025. g. 19. maijs 20:15 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

2025. g. 19. maijs 20:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 19. maijs 19:59 UTC

Top Ziņas

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

2025. g. 19. maijs 19:58 UTC

Tirgus saruna

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

2025. g. 19. maijs 19:52 UTC

Tirgus saruna

Imports Accelerate at Southern California Ports -- Market Talk

Salīdzinājums

Cenas izmaiņa

Vivesto AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.